Arachidonic + docosahexaenoic acid cuts risk for severe retinopathy of prematurity by nearly half

Arachidonic acid (AA) and docosahexaenoic acid (DHA) decrease the risk for severe retinopathy of prematurity (ROP) in extremely preterm infants by nearly half, according to a research letter published online in JAMA Ophthalmology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup